Tenax Therapeutics(TENX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TENX Tenax Therapeutics

Trading 08-11 15:10:17 EDT

1.65

+0.27

+19.64%

High1.84	Low1.43	Vol29.39M
Open1.44	D1 Closing1.38	Amplitude29.82%
Mkt Cap61.56M	Tradable Cap28.81M	Total Shares37.42M
T/O48.95M	T/O Rate167.78%	Tradable Shares17.52M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TENX","market":"US","secType":"STK","nameCN":"Tenax Therapeutics","latestPrice":1.645,"timestamp":1786475411814,"preClose":1.375,"halted":0,"volume":29387117,"delay":0,"changeRate":0.19636363636363638,"floatShares":17515100,"shares":37423900,"eps":-1.468475,"marketStatus":"Trading","change":0.27,"latestTime":"08-11 15:10:17 EDT","open":1.44,"high":1.84,"low":1.43,"amount":48951954.5430008,"amplitude":0.298182,"askPrice":1.65,"askSize":2761,"bidPrice":1.64,"bidSize":1292,"shortable":0,"etf":0,"ttmEps":-1.468475,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1786478400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.375,"preHourTrading":{"tag":"盘前","latestPrice":1.44,"preClose":1.375,"latestTime":"09:29 EDT","volume":813625,"amount":1184955.801925,"timestamp":1786454969459,"change":0.065,"changeRate":0.047273,"amplitude":0.08},"postHourTrading":{"tag":"盘后","latestPrice":1.46,"preClose":1.375,"latestTime":"19:59 EDT","volume":2025380,"amount":2884779.7652,"timestamp":1786406398837,"change":0.085,"changeRate":0.061818,"amplitude":0.08},"volumeRatio":2.291835,"impliedVol":1.6218,"impliedVolPercentile":0.4167},"requestUrl":"/m/hq/s/TENX/wiki","defaultTab":"wiki","newsList":[{"id":"2658911402","title":"Tenax Therapeutics downgraded to Neutral from Buy at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911402?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:40","pubTimestamp":1786462820,"startTime":"0","endTime":"0","summary":"Chardan downgraded Tenax Therapeutics (TENX) to Neutral from Buy with a $5 price target down from $27, after the company announced that the LEVEL P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-downgraded-to-neutral-from-buy-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-downgraded-to-neutral-from-buy-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658291826","title":"Tenax Therapeutics Price Target Cut to $5.00/Share from $39.00 by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2658291826","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658291826?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:48","pubTimestamp":1786452480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TENX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658165992","title":"Evercore ISI Downgrades Tenax Therapeutics to In Line From Outperform, Adjusts PT to $5 From $39","url":"https://stock-news.laohu8.com/highlight/detail?id=2658165992","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658165992?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:18","pubTimestamp":1786447101,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics (TENX) has an average rating of buy and mean price target of $21.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994767","title":"Tenax Therapeutics Inc : William Blair Cuts to Market Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994767","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994767?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:03","pubTimestamp":1786446232,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN44811D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658991508","title":"Tenax Therapeutics price target lowered to $4 from $26 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2658991508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658991508?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:15","pubTimestamp":1786443339,"startTime":"0","endTime":"0","summary":"Leerink lowered the firm’s price target on Tenax Therapeutics (TENX) to $4 from $26 and keeps an Outperform rating on the shares. Published first o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-price-target-lowered-to-4-from-26-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-price-target-lowered-to-4-from-26-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658961819","title":"Tenax Therapeutics Inc : Canaccord Genuity Cuts Target Price to $4 from $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2658961819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658961819?lang=en_us&edition=fundamental","pubTime":"2026-08-11 12:24","pubTimestamp":1786422256,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN44802S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658584939","title":"Tenax Therapeutics downgraded to Market Perform from Outperform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2658584939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658584939?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:55","pubTimestamp":1786380912,"startTime":"0","endTime":"0","summary":"William Blair analyst Matthew Phipps downgraded Tenax Therapeutics (TENX) to Market Perform from Outperform after the company announced that the Ph...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-downgraded-to-market-perform-from-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-downgraded-to-market-perform-from-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658958307","title":"U.S. Stocks on the MOVE-Microsoft, Coastal Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658958307","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658958307?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:33","pubTimestamp":1786379620,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Microsoft, Coastal FinancialAugust 10 (Reuters)-Wall Street's main indexes inched lower on Monday after the S&P 500 and the Dow hit record highs last week, as investors we","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL6N4470RT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DUK","ACHR","UAL","SIMO","AAL","ABCL","INTC","SPCF","DAL","MSFT","EVTL","NESR","CHMI","AIQ","CSQR","JBLU","AAPL","COHR","TTD","HZO","XOM","NETG","LINT","AIRS","AAON","CCB","SCKT","APA","VATE","BWMN","TENX","VRTX","SPCH","LITE","STDN","GME","EBAY","OXY","TDIV","VREX","VRSK","SION","TH","CECO","RHP","SPCX","CVX","NET","BA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993737","title":"Tenax, Sionna Shares Sink After Trial Failures","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993737","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993737?lang=en_us&edition=fundamental","pubTime":"2026-08-10 22:52","pubTimestamp":1786373520,"startTime":"0","endTime":"0","summary":"Shares of Tenax Therapeutics and Sionna Therapeutics tumbled Monday after the biotechs revealed separate late-stage trial failures.Tenax stock fell nearly 90% after a Phase 3 trial of its experimental heart-failure pill failed to help patients walk farther than those on a placebo. The trial measured how far patients could walk in six minutes-a standard test for heart failure treatments. A second trial goal measuring patient-reported symptoms also came up short.Meanwhile, shares of Sionna dropped 92% after a trial of its experimental cystic fibrosis drug missed its main goal. The drug, added to a treatment developed by Vertex Pharmaceuticals, was meant to help patients' lungs clear mucus more effectively, measured by a drop in sweat chloride levels. The company said it wouldn't continue development of the drug as an add-on treatment.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TENX","SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993969","title":"Tenax Therapeutics Exec Says Two Deaths Occurred During Double-Blind Phase, with Investigators Determining Both were Unrelated to Tnx-103- Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993969","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993969?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:46","pubTimestamp":1786365987,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470FJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658363479","title":"Quanterix Q2 Revenue Rises 34% but Cuts 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658363479","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658363479?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:12","pubTimestamp":1786363958,"startTime":"0","endTime":"0","summary":"Quanterix Q2 revenue rises 34% but cuts 2026 outlookOverviewPrecision biomarker science firm's Q2 revenue rose 34% yr/yr amid execution challenges and market softnessAdjusted EBITDA loss for Q2 narrow","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","BK4551","BK4196","BK4585","LU2065731478.USD","DOCS","BK4588","BK4139","RDNT","BK4613","TENX","QTRX","BK4121","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658935519","title":"U.S. Stocks on the MOVE-Apple, Barrick Mining, AbCellera Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2658935519","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658935519?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:55","pubTimestamp":1786362928,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Apple, Barrick Mining, AbCellera BiologicsAug 10 -S&P 500 and Nasdaq futures inched higher on Monday as investors assessed developments in the Middle East that could influence the reopening of the Strait of Hormuz, kicking off the week laden with crucial inflation data and earnings..N** Barrick Mining CorpB.N:BUZZ - Falls on Q2 profit missnL4N4470KX** Apple IncAAPL.O:BUZZ - Falls, Jefferies downgrades on anniversary iPhone concernsnL6N4470IQ** National Energy Services Reunited CorpNESR.O:BUZZ - Jumps on Q2 revenue beatnL6N4470ID** Varex Imaging CorpVREX.O:BUZZ - Jumps as Teledyne to buy X-ray imaging maker in $1.1 billion dealnL4N4470MN** Tenax Therapeutics IncTENX.O:BUZZ - Falls after heart drug misses late-stage study goalnL4N4470NC** AbCellera Biologics IncABCL.O:BUZZ - Gains as experimental drug reduces hot flashes in mid-stage trialnL4N4470NT** Sionna Therapeutics IncSION.O:BUZZ - Falls after experimental drug misses mid-stage trial goalnL4N4470NN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL6N4470K0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPX","LU2458330169.SGD","LU2462157665.USD","LU0795875086.SGD","LU2552382058.USD","LU0061474960.USD","LU2543165471.USD","LU0210536198.USD","HK0000320264.USD","BK4571","LU2456880835.USD","LU2271345857.HKD","SG9999015952.SGD","LU0784385170.HKD","LU1244550494.USD","BK4179","IE00BKDWB100.SGD","LU2750360641.GBP","LU0203201768.USD","LU0612318385.USD","LU0861579265.USD","IE00BJTD4V19.USD","LU1064131342.USD","TDY","LU3102509885.SGD","LU1267930490.SGD","NESR","LU0314104364.USD","LU1934455194.USD","LU1366333091.USD","LU2430703095.HKD","LU1791710582.SGD","IXN","LU2237443895.HKD","LU1935042215.USD","AAPU","IE00BJJMRY28.SGD","VREX","LU2063271972.USD","LU0456855351.SGD","BK4575","LU0965509283.SGD","LU2896262040.SGD","LU1202635105.USD","LU0345770993.USD","AAPB","LU0820561909.HKD","LU1291159041.SGD","LU1629891620.HKD","LU2250418816.HKD","LU2430703251.USD","IE00B19Z8W00.USD","LU1261432733.SGD","LU2461242641.AUD","LU1316542783.SGD","LU0823434740.USD","LU1116320737.USD","LU0203202063.USD","LU1732800096.USD","LU0738911758.USD","LU1778281490.HKD","LU1989772923.USD","LU2458330243.SGD","LU1979441026.SGD","LU2756315318.SGD","LU0234570918.USD","LU0612318971.USD","LU1037948897.HKD","EYES","LU0289961442.SGD","LU0795875169.SGD","LU1066051225.USD","LU2065171311.SGD","IE00BQXX3F31.USD","HK0000819398.USD","LU1803068979.SGD","IE00B1XK9C88.USD","LU2089283258.USD","IE0009356076.USD","LU2417539215.USD","LU2360032135.SGD","LU0784385840.USD","LU2361044949.HKD","LU0354030511.USD","LU0417517546.SGD","TTXU","LU0211328371.USD","LU0345768153.USD","IE00BYXW3230.USD","LU0742534661.SGD","LU0354030438.USD","LU0630314457.HKD","LU0128525929.USD","LU1868836757.USD","LU2133065610.SGD","LU1430597077.USD","IE0004091025.USD","BK4161","LU0109391861.USD","LU0964807845.USD","LU2242649171.HKD","LU2750360997.AUD","IE00BQXX3C00.GBP","LU2265009873.SGD","LU0868494617.USD","LU0724618789.USD","LU0057025933.USD","IE0001KFT4U8.USD","BU","LU0882574139.USD","LU2462591350.SGD","LU2954938101.SGD","SGXZ80539844.SGD","SG9999017495.SGD","BK4564","LU0353189763.USD","LU0494093205.USD","LU1023059493.AUD","IE00B1BXHZ80.USD","LU2108987350.USD","APLY","LU1035775433.USD","LU2077746001.SGD","IE000MB6IJN5.SGD","IE00B7KXQ091.USD","LU0788109477.HKD","SION","IE0004086264.USD","LU0528227936.USD","LU2471134523.USD","BK4505","BK4017","LU1914381329.SGD","LU0985320562.USD","LU0096362180.USD","LU2592432038.USD","LU0823417737.USD","LU0444973449.USD","LU2505996509.AUD","LU2403377893.USD","SG9999014567.USD","LU0256863811.USD","LU2168564065.EUR","LU2452424414.USD","IE00BLSP4452.SGD","SG9999002224.SGD","LU0661504455.SGD","LU0689472784.USD","LU0949170772.SGD","LU0265550359.USD","LU1548497426.USD","LU0048573561.USD","B","LU0965508806.USD","LU2505996681.GBP","LU1242518931.SGD","LU1852331112.SGD","IE00B3S45H60.SGD","LU1988902786.USD","IE00BQXX3D17.EUR","LU1720051017.SGD","LU1868837136.USD","LU1935043536.SGD","SG9999000418.SGD","CMAG","BK4515","LU1571399168.USD","LU2347655156.SGD","LU1989764664.SGD","LU1242518857.USD","BK4592","LU0323591593.USD","LU0345769128.USD","LU2083900584.USD","LU1974910355.USD","LU2092627202.USD","LU0267386448.USD","LU2420271590.USD","LU2347655073.USD","LU0096364046.USD","LU0320765059.SGD","LU0957808578.USD","LU0957791311.USD","LU0061475181.USD","LU0310799852.SGD","LU0708994859.HKD","FTEC","LU2286300806.USD","IE00BK4W5M84.HKD","LU2237443382.USD","LU0786609619.USD","LU1127390331.HKD","LU1244550221.USD","LU1551013342.USD","LU2264538146.SGD","LU0965509101.SGD","LU1267930730.SGD","LU0081259029.USD","LU2168564222.USD","LU2092937148.SGD","LU2087621335.USD","LU0345768740.USD","SG9999014880.SGD","LU2065171402.SGD","LU0965509010.AUD","LU0210533765.USD","BK4581","MACW.SI","LU2237443549.SGD","LU0314106906.USD","LU1720051108.HKD","LU1582987597.SGD","LU0345770308.USD","LU0654597011.USD","LU2054465674.USD","IE00BMPRXN33.USD","LU1732799900.SGD","LU0784384876.USD","LU2213496289.HKD","IE00BDCRKT87.USD","LU0708995401.HKD","HK0000914686.HKD","LU0075056555.USD","HK0000306701.USD","BK4559","IE0034235303.USD","LU2065170008.USD","LU2023251221.USD","BK4535","IE000BZT7R73.USD","IE000F7OJYX1.SGD","LU0466842654.USD","LU1003077747.HKD","BK4598","LU1582986433.USD","LU1066051811.HKD","LU1206712785.SGD","LU1066051498.USD","LU1642822529.SGD","BK4579","LU2506952170.USD","LU2860962120.EUR","LU2028103732.USD","LU2471134796.USD","IE000KEQY171.SGD","IE00BFSS8Q28.SGD","GB00BDT5M118.USD","SG9999015978.USD","LU0124676726.USD","LU0912757837.SGD","BK4554","BK4574","METV","LU0784383803.USD","LU0080751232.USD","LU0330918003.SGD","IE0004445015.USD","TENX","HK0000532082.HKD","SG9999015358.SGD","LU1267930573.SGD","AAPD","LU0234572021.USD","IE00BMPRXR70.SGD","VT","VGT","LU0889565833.HKD","BK4533","LU1069344957.HKD","IE000Q6AESB8.SGD","SG9999001143.SGD","SG9999014898.SGD","LU2100268510.USD","TYLG","LU0158827948.USD","AAPL","LU0444971666.USD","LU2237443978.SGD","LU0787776722.HKD","LU1989771016.USD","LU0082616367.USD","SG9999015341.SGD","LU0215105999.USD","BK4576","LU1145028129.USD","LU1119994496.HKD","LU0724617625.USD","IE00B19Z9505.USD","LU2602419157.SGD","SG9999014575.USD","IE00B19Z8X17.USD","IE00BBT3K403.USD","LU0345769631.USD","LU0072462426.USD","LU1839511570.USD","BK4157","LU0157215616.USD","LU0048584097.USD","LU2462591277.SGD","IE000WAW04H5.SGD","BK4512","LU1917777945.USD","LU0689626769.HKD","LU0345780521.USD","LU1935042991.SGD","LU0109392836.USD","LU2237438978.USD","LU0672654240.SGD","LU1699723380.USD","LU1084165304.USD","LU0011850046.USD","LU1934455863.HKD","LU0640476718.USD","LU1815333072.USD","LU0308772762.SGD","LU1674673428.USD","LU1935043023.USD","SG9999014542.SGD","BK4534","LU0210528500.USD","IE00BFSS7M15.SGD","BK4139","LU1366192091.USD","LU0070217475.USD","LU2125154778.USD","LU2247934214.USD","LU0149725797.USD","IE0034235295.USD","ABCL","SG9999014559.SGD","IE00BN29S564.USD","IE000SO60NU8.SGD","LU1066053197.SGD","LU1935042488.USD","LU1206713676.USD","LU1301847155.USD","LU0077335932.USD","LU1582987324.SGD","LU2552382132.HKD","LU2361044865.SGD","LU0300736492.USD","LU0070302665.USD","LU0345780281.USD","LU1046421795.USD","LU0823421416.USD","LU1674673691.USD","IE00BSNM7G36.USD","LU0079474960.USD","LU0642271901.SGD","IE0009G5SDU7.USD","LU0557290698.USD","LU2111349929.HKD","AAPW","LU0072461881.USD","BK4501","LU0498741114.HKD","LU0170899867.USD","LU0553294199.USD","LU1791710400.SGD","LU1037948541.HKD","LU2047632596.USD","LU0368265764.SGD","LU2430703178.SGD","LU1804176565.USD","IE00BJLML261.HKD","IE00B4YYXB79.USD","BK4585","LU1506573853.SGD","LU1718418525.SGD","LU2381873111.SGD","HK0000320223.HKD","IE00BLSP4239.USD","LU0053666078.USD","LU0949170426.SGD","LU0979878070.USD","LU0310800379.SGD","IE00BZ1G4Q59.USD","LU1868836914.USD","SGXZ31699556.SGD","IE00BJTD4N35.SGD","LU0496367417.USD","LU1400636574.HKD","BK4566","BK4588","LU2361045086.USD","LU2746668974.SGD","AAPY","LU2168563687.JPY","SG9999001424.SGD","BK4170","ABFL","LU0820562030.AUD","XLK","LU1645745479.HKD","LU0198837287.USD","LU1244550577.SGD","IE00BWXC8680.SGD","LU2746668461.USD","LU2357305700.SGD","LU0029864427.USD","LU0300736062.USD","LU1868837300.USD","LU0950375773.USD","LU2023250843.SGD","IE0004445239.USD","LU1496350171.SGD","LU0820561818.USD","LU1280957306.USD","LU0683600562.USD","LU0823417653.USD","LU1815336760.USD","IE00BDRTCR15.USD","BK4573","LU0158827781.USD","LU2168564149.EUR","IE00BK4W5L77.USD","LU2237443465.HKD","LU0472753341.HKD","LU0498741890.SGD","IE00BMPRXQ63.HKD","BZZ","LU2168564495.EUR","LU0316494557.USD","IE00B775SV38.USD","IE000YTNTUN2.SGD","IE000ITXATA3.USD","LU0943347566.SGD","LU2106854487.HKD","LU0162691827.USD","LU0055631609.USD","LU0208291251.USD","LU2023250504.SGD","BK4527","LU1814569148.SGD","LU0143551892.USD","LU2236285917.USD","LU2471134952.CNY","IE00B4JS1V06.HKD","SPTE","LU2487616109.SGD","LU1551013425.SGD","IE0005OL40V9.USD","LU0251131958.USD","BK4532","LU2089284900.SGD","IE0003U64NQ7.SGD","LU2191332357.HKD","SG9999002521.SGD","LU0320765489.SGD","LU2471134879.HKD","LU1670756490.USD","LU0788108826.HKD","SG9999018865.SGD","LU0251132253.USD","LU2023250330.USD","LU2999663052.SGD","LU0942090050.USD","LU0133085943.USD","LU1232071149.USD","IE000W1ABFV2.USD","LU1400636491.USD","IE00B775H168.HKD","HK0000306685.HKD","LU0476273544.USD","BK4082","SG9999002232.USD","BK4550","LU0238689110.USD","LU0289739343.SGD","LU2125154935.USD","LU2097344431.USD","LU2552382215.SGD","LU0788109121.HKD","AAPE","LU0265550946.USD","HK0000914660.USD","LU2506951875.HKD","IE0000B7K699.USD","LU0256863902.USD","LU0511384066.AUD","LU1074936037.SGD","LU0719512351.SGD","LU2242650005.HKD","IE00B5949003.HKD","SG9999014906.USD","SG9999018857.SGD","LU0097036916.USD","SG9999015945.SGD","LU0056508442.USD","LU1116320901.HKD","LU1823568750.SGD","LU0251142724.SGD","LU2506951958.HKD","LU0174119429.USD","LU2637965513.SGD","SG9999014914.USD","LU0353189680.USD","LU0211327993.USD","BK4507","LU2237443622.USD","BK4553","LU1235294995.USD","LU1400636657.SGD","LU0345780950.USD","LU2065169927.USD","LU0348723411.USD","LU0823421333.USD","LU1868836591.USD","ROM","LU2506952097.USD","LU0868494708.USD","IE00BKVL7J92.USD","LU2087625088.SGD","LU2360106780.USD","LU1989764748.USD","SG9999015986.USD","LU2097344357.USD","JGRO","LU0726765562.USD","LU0545039389.USD","BK4121","LU1496350502.SGD","IE00BJJMRX11.SGD","LU0154236417.USD","LU0823434583.USD","LU0069063385.USD","LU1934455277.USD","IE00BN8TJ469.HKD","LU1582986359.USD","LU0127658192.USD","LU2756315664.SGD","IE00B3SWFQ91.USD","LU0345781412.USD","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658933672","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933672","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658933672?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:28","pubTimestamp":1786361331,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics (SION) shares were down more than 92% premarket Monday after the company said that a phase 2a proof-of-concept trial for its cystic fibrosis drug, SION-719, failed to meet its prim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4196","TENX","MB","DSY","SION","AIRS","BK4209","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938032","title":"Orion: Tenax's Trial Did not Reach Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938032","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938032?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:18","pubTimestamp":1786360697,"startTime":"0","endTime":"0","summary":"Aug 10 (Reuters) - Orion Oyj::*LICENSE PARTNER TENAX THERAPEUTICS' PHASE 3 LEVEL TRIAL DID NOT REACH ITS PRIMARY ENDPOINT*TRIAL WAS PHASE 3 LEVEL TRIAL OF ORAL LEVOSIMENDAN IN PULMONARY HYPERTENSION D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nRSD2FgKCb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658387629","title":"Tenax Therapeutics Falls After Heart Drug Misses Late-Stage Study Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2658387629","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658387629?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:15","pubTimestamp":1786360511,"startTime":"0","endTime":"0","summary":"BUZZ-Tenax Therapeutics falls after heart drug misses late-stage study goal** Shares of drug developer TenaxTENX.Ofall 83.9% to $2.16 premarket** Co's experimental heart drugfailsto meet the main goal of a late-stage study** TENX was testing TNX-103 in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction, or HFpEF** Up to last close, stock up 10.3% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470NC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658393823","title":"Tenax Therapeutics Shares Plunge 84.4% Premarket After Co's Heart Drug Did not Meet Main Goal in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2658393823","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658393823?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:12","pubTimestamp":1786360375,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470NB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658384979","title":"Tenax Therapeutics Phase 3 Level Trial Misses Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2658384979","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658384979?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:09","pubTimestamp":1786360164,"startTime":"0","endTime":"0","summary":"BRIEF-Tenax Therapeutics Phase 3 Level Trial Misses Primary EndpointAug 10 (Reuters)-Orion OyjORNBV.HE:LICENSE PARTNER TENAX THERAPEUTICS' PHASE 3 LEVEL TRIAL DID NOT REACH ITS PRIMARY ENDPOINTTRIAL W","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470N7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938996","title":"Tenax Says Phase 3 LEVEL Trial of TNX-103 in PH-HFpEF Misses Primary Endpoint on 6-Minute Walk Distance","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938996","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938996?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:04","pubTimestamp":1786359875,"startTime":"0","endTime":"0","summary":"Tenax says Phase 3 LEVEL trial of TNX-103 in PH-HFpEF misses primary endpoint on 6-minute walk distanceTenax Therapeutics reported topline Phase 3 LEVEL results for TNX-103 in PH-HFpEF; full data will","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL9h6tyv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014005.SGD","BK4112","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","BCDF","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014021.USD","SG9999014013.SGD","IE00BGHQF748.EUR","LU0314104364.USD","SG9999014039.USD","LU2210150020.SGD","LU2095319765.USD","NDAQ","TENX","IE00BN0W2V16.EUR","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658962938","title":"Tenax Therapeutics' Heart Drug Misses Main Goal in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2658962938","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658962938?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:04","pubTimestamp":1786359840,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics' heart drug misses main goal in late-stage studyAug 10 (Reuters)-Tenax TherapeuticsTENX.Osaid on Monday its experimental heart drug failed to meet the main goal of a late-stage study.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658800969","title":"Tenax Therapeutics - Tnx-103 Generally Safe and Well Tolerated in Level Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658800969","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658800969?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUAGCJ7H:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tenaxthera.com","stockEarnings":[{"period":"1week","weight":-0.904},{"period":"1month","weight":-0.9217},{"period":"3month","weight":-0.887},{"period":"6month","weight":-0.8942},{"period":"1year","weight":-0.7673},{"period":"ytd","weight":-0.8872}],"compareEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":0.0239},{"period":"3month","weight":0.0472},{"period":"6month","weight":0.1172},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1336}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension in the United States. The company develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.174007},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.128329},{"month":3,"riseRate":0.416667,"avgChangeRate":0.025378},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.034902},{"month":5,"riseRate":0.363636,"avgChangeRate":0.065949},{"month":6,"riseRate":0.583333,"avgChangeRate":-0.020009},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.003191},{"month":8,"riseRate":0.25,"avgChangeRate":-0.118419},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.018463},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.070479},{"month":11,"riseRate":0.583333,"avgChangeRate":0.07352},{"month":12,"riseRate":0.666667,"avgChangeRate":0.039185}],"exchange":"NASDAQ","name":"Tenax Therapeutics","nameEN":"Tenax Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tenax Therapeutics(TENX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tenax Therapeutics(TENX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tenax Therapeutics,TENX,Tenax Therapeutics股票,Tenax Therapeutics股票老虎,Tenax Therapeutics股票老虎国际,Tenax Therapeutics行情,Tenax Therapeutics股票行情,Tenax Therapeutics股价,Tenax Therapeutics股市,Tenax Therapeutics股票价格,Tenax Therapeutics股票交易,Tenax Therapeutics股票购买,Tenax Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tenax Therapeutics(TENX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tenax Therapeutics(TENX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}